Team Miro

Breaking new ground in immunology to help patients around the world

At MiroBio, we are driven to deliver transformational immunotherapies for people living with immune-mediated inflammatory disease, building on our unique expertise in checkpoint agonist antibody engineering.

Our Leadership

We are bringing together world-class expertise and drug development talent to make MiroBio an innovative force in immunology and turn our vision into a reality. We are united by the promise of an exciting new field and a thriving culture which celebrates scientific rigor, inclusivity, patient-first thinking and collaborative energy.

Carolin Barth, MD

Chief Executive Officer


Lynne Murray, PhD, MBA

SVP, Research and Development


Eliot Charles, PhD, MBA

Executive Chair


Srinivas Akkaraju, MD, PhD


Shahzad Malik, MD


Debbie Harland, PhD, MBA



Richard Cornall, MD, PhD, FMedSci

Co-founder, Scientific Advisor


Simon Davis, PhD

Co-founder, Scientific Advisor

Jason G. Cyster, PhD

Tomas Mustelin, MD, PhD

Robert Stein, MD, PhD

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser